ERBB2 and neoplasm: The novel version of the Oncotype DX medical report includes a short statement that the reported single gene expression scores are for quality control purposes, but it is not defined if they only confirm the inclusion criteria of a Her2 negative ER positive status of the investigated tumor or if the controls provide information about assay performance.